Literature DB >> 16804724

Prognostic value of cell cycle regulatory proteins in muscle-infiltrating bladder cancer.

Fabia Galmozzi1, Alessandra Rubagotti, Andrea Romagnoli, Giorgio Carmignani, Luisa Perdelli, Beatrice Gatteschi, Francesco Boccardo.   

Abstract

PURPOSE: The aims of this study were to investigate the expression levels of proteins involved in cell cycle regulation in specimens of bladder cancer and to correlate them with the clinicopathological characteristics, proliferative activity and survival.
METHODS: Eighty-two specimens obtained from patients affected by muscle-invasive bladder cancer were evaluated immunohistochemically for p53, p21 and cyclin D1 expression, as well as for the tumour proliferation index, Ki-67. The statistical analysis included Kaplan-Meier curves with log-rank test and Cox proportional hazards models.
RESULTS: In univariate analyses, low Ki-67 proliferation index (P = 0.045) and negative p21 immunoreactivity (P = 0.04) were associated to patient's overall survival (OS), but in multivariate models p21 did not reach statistical significance. When the combinations of the variables were assessed in two separate multivariate models that included tumour stage, grading, lymph node status, vascular invasion and perineural invasion, the combined variables p21/Ki-67 or p21/cyclin D1 expression were independent predictors for OS; in particular, patients with positive p21/high Ki-67 (P = 0.015) or positive p21/negative cyclin D1 (P = 0.04) showed the worst survival outcome.
CONCLUSIONS: Important alterations in the cell cycle regulatory pathways occur in muscle-invasive bladder cancer and the combined use of cell cycle regulators appears to provide significant prognostic information that could be used to select the patients most suitable for multimodal therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16804724     DOI: 10.1007/s00432-006-0123-7

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  27 in total

Review 1.  The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee.

Authors:  J I Epstein; M B Amin; V R Reuter; F K Mostofi
Journal:  Am J Surg Pathol       Date:  1998-12       Impact factor: 6.394

Review 2.  Cyclin D1 and human neoplasia.

Authors:  R Donnellan; R Chetty
Journal:  Mol Pathol       Date:  1998-02

3.  p53 and p21 Expression levels predict organ preservation and survival in invasive bladder carcinoma treated with a combined-modality approach.

Authors:  Xavier Garcia del Muro; Enric Condom; Francesc Vigués; Xavier Castellsagué; Agnès Figueras; Josep Muñoz; Judit Solá; Teresa Soler; Gabriel Capellà; Josep R Germà
Journal:  Cancer       Date:  2004-05-01       Impact factor: 6.860

4.  pRB plays an essential role in cell cycle arrest induced by DNA damage.

Authors:  E A Harrington; J L Bruce; E Harlow; N Dyson
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

5.  Prognostic factors in muscle-invasive bladder cancer treated with radiotherapy: an immunohistochemical study.

Authors:  I Osen; S D Fosså; B Majak; R Røtterud; A Berner
Journal:  Br J Urol       Date:  1998-06

Review 6.  Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis.

Authors: 
Journal:  Lancet       Date:  2003-06-07       Impact factor: 79.321

7.  Frequent and heterogeneous expression of cyclin-dependent kinase inhibitor WAF1/p21 protein and mRNA in urothelial carcinoma.

Authors:  S Clasen; W A Schulz; C D Gerharz; M O Grimm; F Christoph; B J Schmitz-Dräger
Journal:  Br J Cancer       Date:  1998-02       Impact factor: 7.640

8.  Proliferation- and apoptosis-associated factors in advanced prostatic carcinomas before and after androgen deprivation therapy: prognostic significance of p21/WAF1/CIP1 expression.

Authors:  G B Baretton; U Klenk; J Diebold; N Schmeller; U Löhrs
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

9.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

10.  Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.

Authors:  V M Tut; K L Braithwaite; B Angus; D E Neal; J Lunec; J K Mellon
Journal:  Br J Cancer       Date:  2001-01       Impact factor: 7.640

View more
  7 in total

1.  Clinicopathologic and prognostic significance of p21 (Cip1/Waf1) expression in bladder cancer.

Authors:  Kun Tang; Chenghe Wang; Zhong Chen; Hua Xu; Zhangqun Ye
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

Review 2.  Prognostic value of cell-cycle regulation biomarkers in bladder cancer.

Authors:  Anirban P Mitra; Donna E Hansel; Richard J Cote
Journal:  Semin Oncol       Date:  2012-10       Impact factor: 4.929

3.  The impact of cyclin D1 overexpression on the prognosis of bladder cancer: a meta-analysis.

Authors:  Baoming Ren; Wenjun Li; Yanping Yang; Songdi Wu
Journal:  World J Surg Oncol       Date:  2014-03-06       Impact factor: 2.754

Review 4.  High Ki-67 Immunohistochemical Reactivity Correlates With Poor Prognosis in Bladder Carcinoma: A Comprehensive Meta-Analysis with 13,053 Patients Involved.

Authors:  Yihuan Luo; Xin Zhang; Meile Mo; Zhong Tan; Lanshan Huang; Hong Zhou; Chunqin Wang; Fanglin Wei; Xiaohui Qiu; Rongquan He; Gang Chen
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

Review 5.  Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis.

Authors:  Yuejun Tian; Zhiming Ma; Zhaohui Chen; Mingguo Li; Zhiping Wu; Mei Hong; Hanzhang Wang; Robert Svatek; Ronald Rodriguez; Zhiping Wang
Journal:  PLoS One       Date:  2016-07-13       Impact factor: 3.240

6.  The Prognostic Value of Cell Cycle Gene Expression Signatures in Muscle Invasive, High-Grade Bladder Cancer.

Authors:  Garrett M Dancik; Dan Theodorescu
Journal:  Bladder Cancer       Date:  2015-04-30

Review 7.  Roles of SPARC in urothelial carcinogenesis, progression and metastasis.

Authors:  Neveen Said
Journal:  Oncotarget       Date:  2016-10-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.